Pacific Venture Group is a private equity and venture capital firm specializing in early and expansion-stage investments.
Business Model:
Revenue: $7.3M
Employees: 11-50
Address: 16830 Ventura Blvd
City: Encino
State: CA
Zip: 91436
Country: US
Pacific Venture Group is a private equity and venture capital firm specializing in early and expansion-stage investments. The firm seeks to invest in companies at all stages of financing from start-up to leveraged buyout, recapitalizations, and consolidations. It typically invests across all segments of healthcare and information systems including healthcare information technology, medical devices, biopharmaceuticals, and healthcare services. Within healthcare information technology, the firm focuses on infrastructure solutions, leverage professional staffing, technology based outsource solutions, and clinical quality improvement. Within medical devices, it focuses on unmet therapeutic needs and disposables, cost effective medical devices, small equipments, and medical devices that enhance quality of life. Within biopharmaceuticals, the firm invests in drug delivery, drug discovery, specialty pharmaceuticals, and in licensing. Within healthcare services, it focuses on new care delivery models, outsourcing, healthcare staffing solutions, and recapitalizations and spinouts from larger companies. The firm invests on a nationwide basis with particular emphasis on the Western United States. It prefers to be the lead investor in its investments. The firm typically invests between $2 million and $5 million, and may invest as much as $10 million over the life of a company. For seed-stage companies, the funding can be as low as $250,000. Pacific Venture Group was founded in 1995 and is based in Encino, California with an additional office in Irvine, California
Contact Phone:
+18189904141
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
8/2000 | Thap! | Series B | 8M |
6/2000 | IC-USA | Series B | 9M |
2/2002 | Virtual Silicon Technology | Series C | 0 |
3/2004 | Inspiris | Series D | 8M |
6/2010 | Nereus Pharmaceuticals | Series E | 0 |
8/2000 | PatientKeeper | Series B | 0 |
3/1997 | SiRF Technology | Venture Round | 8M |
3/2000 | GoToMyDoc | Venture Round | 25M |
6/2001 | Luminous Networks | Series D | 0 |
7/2005 | Centerre Healthcare Corporation | Venture Round | 30M |
6/2002 | Zone Labs | Series C | 0 |
8/2000 | Vasca | Venture Round | 13.2M |
6/2004 | PatientKeeper | Series D | 0 |
2/2003 | AD PathLabs | Series C | 0 |
4/2001 | Intelligent Markets | Series B | 10M |
5/2001 | Zone Labs | Series B | 0 |
10/2000 | Elitra Pharmaceuticals | Venture Round | 0 |
8/2000 | Phase Forward | Venture Round | 25M |
6/2004 | UNISOC | Series C | 0 |
3/2001 | MRxonline | Venture Round | - |
1/2017 | CompareEuropeGroup | Series A | 0 |
11/2004 | Asteres | Series B | - |
7/2001 | Nereus Pharmaceuticals | Series B | 23.6M |
6/2000 | Best3C | Series A | 10M |
11/2005 | Aethon | Series D | 11M |
6/2006 | PatientKeeper | Series E | 0 |
8/2007 | Nereus Pharmaceuticals | Series D | 0 |
11/2007 | Asteres | Series C | 4M |
10/2005 | Nereus Pharmaceuticals | Series D | 0 |
1/2017 | CompareEuropeGroup | Series A | 0 |
6/2010 | Nereus Pharmaceuticals | Series E | 0 |
11/2007 | Asteres | Series C | 0 |
8/2007 | Nereus Pharmaceuticals | Series D | 0 |
6/2006 | PatientKeeper | Series E | 0 |
11/2005 | Aethon | Series D | 0 |
10/2005 | Nereus Pharmaceuticals | Series D | 0 |
7/2005 | Centerre Healthcare Corporation | Venture Round | 0 |
11/2004 | Asteres | Series B | - |
6/2004 | UNISOC | Series C | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|